Skip to content
Disclosery

ORBIMED ADVISORS LLC

Follow

13F filer, CIK 1055951, New York, NY

ORBIMED ADVISORS LLC reported $5,045,363,608 across 113 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 42.8% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-26-002369

Period
2026-03-31
Reported value
$5.05B
Holdings
113
Top 10 weight
42.8%
New
29
Sold out
23

Part of the filer group ORBIMED ADVISORS LLC

How groups are built

Stakes and trades reported after 2026-03-31

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • ADARX PHARMACEUTICALS INC: 13D 14,913,764 shares, 14% of the class, 13D filed 2026-10-02, 0000947871-26-000917
    Accepted , ingested
  • ELECTRA THERAPEUTICS INC: 13D 6,885,170 shares, 11% of the class, 13D filed 2026-09-25, 0000947871-26-000898
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AZNnew+670,200$132M
MRKnew+663,400$79.8M
GHnew+435,200$40.2M
XENEadded+612,771$35.6M
MLYSadded+1,072,500$29.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TERNexited-2,153,300-$87M
APLSexited-2,429,868-$61M
LLYreduced-64,400-$59.2M
CIexited-205,000-$56.4M
ALNYreduced-169,800-$56.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001172661-26-002369, largest first. % of portfolio is the value over $4,585,427,111, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,021,721 shares; 2024Q4: 15,021,721 shares; 2025Q1: 15,021,721 shares; 2025Q2: 15,518,492 shares; 2025Q3: 15,518,492 shares; 2025Q4: 15,518,492 shares; 2026Q1: 15,518,492 shares 15,518,492$489M10.66%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,959,538 shares; 2024Q4: 7,959,538 shares; 2025Q1: 7,959,538 shares; 2025Q2: 7,959,538 shares; 2025Q3: 7,959,538 shares; 2025Q4: 7,959,538 shares; 2026Q1: 7,959,538 shares 7,959,538$312M6.8%0Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 337,600 shares; 2024Q4: 337,600 shares; 2025Q1: 337,600 shares; 2025Q2: 337,600 shares; 2025Q3: 301,200 shares; 2025Q4: 301,200 shares; 2026Q1: 236,800 shares 236,800$218M4.75%-64,400Timeline
SVASINOVAC BIOTECH LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,718,735 shares; 2024Q4: 2,718,735 shares; 2025Q1: 2,718,735 shares; 2025Q2: 2,718,735 shares; 2025Q3: 2,718,735 shares; 2025Q4: 2,718,735 shares; 2026Q1: 2,718,735 shares 2,718,735$184M4.02%0Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,273,000 shares; 2024Q4: 3,160,300 shares; 2025Q1: 2,813,200 shares; 2025Q2: 2,813,200 shares; 2025Q3: 2,429,300 shares; 2025Q4: 2,419,300 shares; 2026Q1: 2,382,100 shares 2,382,100$149M3.26%-37,200Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,704,959 shares; 2025Q2: 3,704,959 shares; 2025Q3: 3,704,959 shares; 2025Q4: 3,561,655 shares; 2026Q1: 3,530,702 shares 3,530,702$142M3.09%-30,953Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 670,200 shares 670,200$132M2.88%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,812,215 shares; 2024Q4: 3,812,215 shares; 2025Q1: 4,002,887 shares; 2025Q2: 4,002,887 shares; 2025Q3: 4,002,887 shares; 2025Q4: 3,935,203 shares; 2026Q1: 3,637,887 shares 3,637,887$109M2.37%-297,316Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,943,654 shares; 2024Q4: 6,943,654 shares; 2025Q1: 6,943,654 shares; 2025Q2: 7,165,006 shares; 2025Q3: 7,165,006 shares; 2025Q4: 7,165,006 shares; 2026Q1: 7,165,006 shares 7,165,006$105M2.29%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 204,500 shares; 2024Q4: 189,700 shares; 2025Q1: 206,700 shares; 2025Q2: 208,000 shares; 2025Q3: 172,300 shares; 2025Q4: 146,000 shares; 2026Q1: 136,900 shares 136,900$100M2.18%-9,100Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,145,302 shares; 2025Q1: 1,532,000 shares; 2025Q2: 1,708,000 shares; 2025Q3: 1,684,000 shares; 2025Q4: 1,842,900 shares; 2026Q1: 1,230,600 shares 1,230,600$98.5M2.15%-612,300Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 433,800 shares; 2024Q4: 401,700 shares; 2025Q1: 291,000 shares; 2025Q2: 291,000 shares; 2025Q3: 287,200 shares; 2025Q4: 263,400 shares; 2026Q1: 208,700 shares 208,700$96.2M2.1%-54,700Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 22,362,850 shares; 2024Q4: 22,362,850 shares; 2025Q1: 22,362,850 shares; 2025Q2: 15,219,994 shares; 2025Q3: 15,219,994 shares; 2025Q4: 15,219,994 shares; 2026Q1: 15,219,994 shares 15,219,994$80.5M1.76%0Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,316,000 shares; 2024Q4: 829,900 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 663,400 shares 663,400$79.8M1.74%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 383,705 shares; 2024Q4: 652,028 shares; 2025Q1: 652,028 shares; 2025Q2: 1,199,300 shares; 2025Q3: 1,139,300 shares; 2025Q4: 1,161,803 shares; 2026Q1: 1,475,403 shares 1,475,403$71.1M1.55%+313,600Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,027,328 shares; 2024Q4: 3,027,328 shares; 2025Q1: 3,027,328 shares; 2025Q2: 3,027,328 shares; 2025Q3: 3,027,328 shares; 2025Q4: 3,027,328 shares; 2026Q1: 3,027,328 shares 3,027,328$69.8M1.52%02026-10-06, 13D/A: 2,875,962 shares, 5.8% of the class, 13D/A filed 2026-10-08 Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,785,571 shares; 2024Q4: 1,785,571 shares; 2025Q1: 1,415,020 shares; 2025Q2: 1,415,020 shares; 2025Q3: 1,415,020 shares; 2025Q4: 1,067,550 shares; 2026Q1: 1,067,550 shares 1,067,550$68.3M1.49%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 8,288,510 shares; 2024Q4: 8,288,510 shares; 2025Q1: 8,288,510 shares; 2025Q2: 8,288,510 shares; 2025Q3: 8,288,510 shares; 2025Q4: 8,288,510 shares; 2026Q1: 8,288,510 shares 8,288,510$66.6M1.45%0Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 691,114 shares; 2024Q4: 1,431,114 shares; 2025Q1: 2,471,994 shares; 2025Q2: 1,877,850 shares; 2025Q3: 1,726,850 shares; 2025Q4: 1,516,550 shares; 2026Q1: 948,267 shares 948,267$64.2M1.4%-568,283Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 911,420 shares; 2024Q4: 947,877 shares; 2025Q1: 947,877 shares; 2025Q2: 947,877 shares; 2025Q3: 419,600 shares; 2025Q4: 447,200 shares; 2026Q1: 1,059,971 shares 1,059,971$61.6M1.34%+612,771Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 344,400 shares; 2024Q4: 344,400 shares; 2025Q1: 359,200 shares; 2025Q2: 359,200 shares; 2025Q3: 359,200 shares; 2025Q4: 325,000 shares; 2026Q1: 182,500 shares 182,500$60M1.31%-142,500Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 775,000 shares; 2026Q1: 925,000 shares 925,000$56.1M1.22%+150,000Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,002,939 shares; 2024Q4: 1,611,637 shares; 2025Q1: not reported; 2025Q2: 760,351 shares; 2025Q3: 1,469,494 shares; 2025Q4: 980,400 shares; 2026Q1: 2,052,900 shares 2,052,900$55.6M1.21%+1,072,500Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 94,500 shares; 2026Q1: 172,500 shares 172,500$55.6M1.21%+78,000Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,850,200 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,652,900 shares; 2026Q1: 1,946,500 shares 1,946,500$54.7M1.19%+293,600Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 708,400 shares; 2024Q4: 1,227,080 shares; 2025Q1: 1,014,611 shares; 2025Q2: 1,031,400 shares; 2025Q3: 2,314,184 shares; 2025Q4: 2,202,184 shares; 2026Q1: 2,917,884 shares 2,917,884$52.9M1.15%+715,700Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 687,500 shares; 2024Q4: 413,000 shares; 2025Q1: 547,000 shares; 2025Q2: 593,434 shares; 2025Q3: 429,300 shares; 2025Q4: 365,800 shares; 2026Q1: 262,000 shares 262,000$52.4M1.14%-103,800Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 380,000 shares; 2025Q4: 367,900 shares; 2026Q1: 465,700 shares 465,700$51.9M1.13%+97,800Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 5,693,589 shares; 2025Q1: 5,693,589 shares; 2025Q2: 5,693,589 shares; 2025Q3: 5,693,589 shares; 2025Q4: 5,693,589 shares; 2026Q1: 5,693,589 shares 5,693,589$51.2M1.12%0Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 263,100 shares; 2025Q4: 299,800 shares; 2026Q1: 265,800 shares 265,800$50.4M1.1%-34,000Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,034,858 shares; 2025Q3: 3,034,858 shares; 2025Q4: 3,116,011 shares; 2026Q1: 2,806,811 shares 2,806,811$50.2M1.09%-309,200Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 34,400 shares; 2025Q3: 191,905 shares; 2025Q4: 171,977 shares; 2026Q1: 181,977 shares 181,977$41.6M0.91%+10,000Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,306,127 shares; 2025Q4: 6,306,127 shares; 2026Q1: 6,306,127 shares 6,306,127$40.5M0.88%0Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 435,200 shares 435,200$40.2M0.88%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 250,300 shares; 2024Q4: 415,600 shares; 2025Q1: 346,100 shares; 2025Q2: 341,900 shares; 2025Q3: 301,600 shares; 2025Q4: 288,800 shares; 2026Q1: 119,000 shares 119,000$39.4M0.86%-169,800Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,909,256 shares; 2024Q4: 10,909,256 shares; 2025Q1: 10,909,256 shares; 2025Q2: 10,909,256 shares; 2025Q3: 10,909,256 shares; 2025Q4: 10,909,256 shares; 2026Q1: 10,909,256 shares 10,909,256$37.3M0.81%0Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,050,055 shares; 2024Q4: 999,000 shares; 2025Q1: 999,000 shares; 2025Q2: 1,149,000 shares; 2025Q3: 1,099,000 shares; 2025Q4: 999,000 shares; 2026Q1: 999,000 shares 999,000$36.3M0.79%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 386,700 shares; 2025Q2: 427,900 shares; 2025Q3: 531,800 shares; 2025Q4: 253,121 shares; 2026Q1: 213,921 shares 213,921$36.2M0.79%-39,200Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 458,500 shares; 2025Q4: 737,400 shares; 2026Q1: 2,136,149 shares 2,136,149$34.9M0.76%+1,398,749Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 700,000 shares; 2025Q2: 899,281 shares; 2025Q3: 3,641,756 shares; 2025Q4: 3,641,756 shares; 2026Q1: 2,693,929 shares 2,693,929$34.1M0.74%-947,827Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 106,200 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 99,100 shares; 2026Q1: 114,700 shares 114,700$33.6M0.73%+15,600Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,610,600 shares; 2026Q1: 4,715,864 shares 4,715,864$32.8M0.72%+2,105,264Timeline
FBRXFORTE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 600,000 shares; 2025Q1: 593,088 shares; 2025Q2: 1,196,955 shares; 2025Q3: 1,196,955 shares; 2025Q4: 1,196,955 shares; 2026Q1: 1,196,955 shares 1,196,955$31M0.68%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,120,000 shares; 2025Q2: 3,308,400 shares; 2025Q3: 3,308,400 shares; 2025Q4: 3,190,700 shares; 2026Q1: 2,454,400 shares 2,454,400$29.3M0.64%-736,300Timeline
ESPRESPERION THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,965,498 shares; 2026Q1: 10,570,300 shares 10,570,300$29M0.63%+4,604,802Timeline
NPCENEUROPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,406,335 shares; 2024Q4: 3,406,335 shares; 2025Q1: 3,406,335 shares; 2025Q2: 2,614,184 shares; 2025Q3: 2,614,184 shares; 2025Q4: 2,406,335 shares; 2026Q1: 2,096,527 shares 2,096,527$27.6M0.6%-309,808Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 435,900 shares; 2024Q4: 400,000 shares; 2025Q1: 380,000 shares; 2025Q2: 248,512 shares; 2025Q3: 215,152 shares; 2025Q4: 239,800 shares; 2026Q1: 314,100 shares 314,100$27.3M0.6%+74,300Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 84,400 shares; 2024Q4: 84,400 shares; 2025Q1: 129,000 shares; 2025Q2: 46,500 shares; 2025Q3: 46,500 shares; 2025Q4: 46,500 shares; 2026Q1: 46,500 shares 46,500$22.9M0.5%0Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,925,300 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 962,300 shares 962,300$22.5M0.49%newTimeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 12,048,773 shares; 2024Q4: 12,048,773 shares; 2025Q1: 12,048,773 shares; 2025Q2: 12,048,773 shares; 2025Q3: 6,210,899 shares; 2025Q4: 6,210,899 shares; 2026Q1: 6,210,899 shares 6,210,899$22.1M0.48%0
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 263,800 shares; 2025Q4: 488,500 shares; 2026Q1: 497,800 shares 497,800$21.2M0.46%+9,300Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,125,000 shares; 2026Q1: 3,602,450 shares 3,602,450$20.7M0.45%+1,477,450Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 801,144 shares 801,144$20M0.44%newTimeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 275,000 shares 275,000$19.8M0.43%newTimeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,840,500 shares; 2026Q1: 3,832,843 shares 3,832,843$18.4M0.4%-7,657Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 23,500 shares; 2024Q4: 23,500 shares; 2025Q1: 23,500 shares; 2025Q2: 9,200 shares; 2025Q3: 102,745 shares; 2025Q4: 119,800 shares; 2026Q1: 69,100 shares 69,100$17.8M0.39%-50,700Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 134,600 shares 134,600$16.8M0.37%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 912,552 shares; 2024Q4: 1,172,287 shares; 2025Q1: 1,172,287 shares; 2025Q2: 1,172,287 shares; 2025Q3: 1,172,287 shares; 2025Q4: 1,597,287 shares; 2026Q1: 1,737,287 shares 1,737,287$16.3M0.36%+140,000Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 478,400 shares; 2025Q3: 689,000 shares; 2025Q4: 875,487 shares; 2026Q1: 875,487 shares 875,487$15.7M0.34%0Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 804,000 shares 804,000$15.2M0.33%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 675,872 shares; 2024Q4: 742,572 shares; 2025Q1: 481,065 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 353,500 shares; 2026Q1: 369,596 shares 369,596$14.9M0.32%+16,096Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,252,987 shares; 2024Q4: 2,252,987 shares; 2025Q1: 2,252,987 shares; 2025Q2: 2,252,987 shares; 2025Q3: 2,252,987 shares; 2025Q4: 2,252,987 shares; 2026Q1: 2,252,987 shares 2,252,987$14.5M0.32%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,166,000 shares; 2025Q2: 4,166,000 shares; 2025Q3: 4,166,000 shares; 2025Q4: 4,166,000 shares; 2026Q1: 4,166,000 shares 4,166,000$14.4M0.31%0Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 252,300 shares; 2024Q4: not reported; 2025Q1: 44,200 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 39,900 shares 39,900$14M0.31%newTimeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 791,000 shares 791,000$13.9M0.3%newTimeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,796,000 shares; 2025Q4: 2,468,314 shares; 2026Q1: 1,069,147 shares 1,069,147$13.8M0.3%-1,399,167Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,258,566 shares; 2024Q4: 758,566 shares; 2025Q1: 758,566 shares; 2025Q2: 1,210,300 shares; 2025Q3: 1,766,100 shares; 2025Q4: 1,954,426 shares; 2026Q1: 983,600 shares 983,600$13.7M0.3%-970,826Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 901,500 shares; 2025Q4: 1,741,800 shares; 2026Q1: 1,425,200 shares 1,425,200$13.6M0.3%-316,600Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 271,910 shares; 2024Q4: 298,301 shares; 2025Q1: 298,301 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 209,100 shares; 2026Q1: 667,300 shares 667,300$13.3M0.29%+458,200Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,423,470 shares; 2024Q4: 921,959 shares; 2025Q1: 921,959 shares; 2025Q2: 921,959 shares; 2025Q3: 790,901 shares; 2025Q4: 790,901 shares; 2026Q1: 711,811 shares 711,811$12.4M0.27%-79,090Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 371,000 shares; 2026Q1: 322,100 shares 322,100$12.4M0.27%-48,900Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,926,423 shares; 2025Q3: 1,926,423 shares; 2025Q4: 1,102,730 shares; 2026Q1: 548,163 shares 548,163$12.1M0.26%-554,567Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 45,200 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 14,700 shares 14,700$11.4M0.25%newTimeline
CARLCARLSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,252,600 shares; 2025Q4: 1,252,600 shares; 2026Q1: 1,252,600 shares 1,252,600$11.3M0.25%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 813,000 shares; 2024Q4: 509,100 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 61,600 shares 61,600$11.3M0.25%newTimeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 187,199 shares; 2026Q1: 180,599 shares 180,599$8.7M0.19%-6,600Timeline
KROSKEROS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,018,734 shares; 2024Q4: 1,018,734 shares; 2025Q1: 1,018,734 shares; 2025Q2: 1,018,734 shares; 2025Q3: 1,018,734 shares; 2025Q4: 804,212 shares; 2026Q1: 759,155 shares 759,155$8.38M0.18%-45,057Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 151,700 shares; 2024Q4: 245,600 shares; 2025Q1: 197,500 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 59,600 shares 59,600$8.31M0.18%newTimeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 9,816,940 shares 9,816,940$7.85M0.17%newTimeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 967,000 shares; 2024Q4: 967,000 shares; 2025Q1: 967,000 shares; 2025Q2: 967,000 shares; 2025Q3: 1,349,300 shares; 2025Q4: 1,187,300 shares; 2026Q1: 475,165 shares 475,165$7.09M0.15%-712,135Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 574,600 shares; 2026Q1: 226,600 shares 226,600$7M0.15%-348,000Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,027,944 shares; 2026Q1: 1,027,944 shares 1,027,944$7M0.15%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,150,646 shares 1,150,646$6.36M0.14%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 205,400 shares; 2026Q1: 205,400 shares 205,400$5.8M0.13%0Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,866,256 shares 2,866,256$5.75M0.13%newTimeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 151,000 shares 151,000$5.53M0.12%newTimeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,133,405 shares; 2024Q4: 2,133,405 shares; 2025Q1: 2,133,405 shares; 2025Q2: 2,133,405 shares; 2025Q3: 2,133,405 shares; 2025Q4: 3,133,405 shares; 2026Q1: 3,133,405 shares 3,133,405$5.11M0.11%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,900 shares; 2026Q1: 52,000 shares 52,000$5.06M0.11%+26,100Timeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,533,801 shares; 2024Q4: 5,968,451 shares; 2025Q1: 5,968,451 shares; 2025Q2: 5,907,351 shares; 2025Q3: 5,907,351 shares; 2025Q4: 5,822,854 shares; 2026Q1: 1,318,026 shares 1,318,026$4.94M0.11%-4,504,828Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,700 shares; 2026Q1: 42,100 shares 42,100$4.44M0.1%+20,400Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,871,420 shares; 2026Q1: 2,333,000 shares 2,333,000$4.08M0.09%+461,580Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 250,000 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: 250,000 shares; 2025Q4: 125,000 shares; 2026Q1: 167,500 shares 167,500$3.77M0.08%+42,500Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 635,000 shares 635,000$3.47M0.08%newTimeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,070,055 shares; 2024Q4: 1,942,555 shares; 2025Q1: 1,923,855 shares; 2025Q2: 1,923,855 shares; 2025Q3: 1,923,855 shares; 2025Q4: 270,006 shares; 2026Q1: 243,006 shares 243,006$3.45M0.08%-27,000Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 23,200 shares; 2026Q1: 49,100 shares 49,100$3.35M0.07%+25,900Timeline
LFSTLIFESTANCE HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares 500,000$3.19M0.07%newTimeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares 40,000$2.92M0.06%newTimeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 531,163 shares; 2025Q3: 531,163 shares; 2025Q4: 531,163 shares; 2026Q1: 185,011 shares 185,011$2.6M0.06%-346,152Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,377,900 shares; 2024Q4: 4,377,900 shares; 2025Q1: 6,830,300 shares; 2025Q2: 6,830,300 shares; 2025Q3: 5,235,146 shares; 2025Q4: 1,404,902 shares; 2026Q1: 856,353 shares 856,353$2.25M0.05%-548,549Timeline
RCELAVITA MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 544,895 shares 544,895$2.02M0.04%newTimeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 382,400 shares; 2026Q1: 94,400 shares 94,400$1.9M0.04%-288,000Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 378,556 shares; 2025Q4: 378,556 shares; 2026Q1: 378,556 shares 378,556$1.89M0.04%0Timeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,060,000 shares; 2025Q4: 3,060,000 shares; 2026Q1: 3,060,000 shares 3,060,000$1.75M0.04%0Timeline
ATAIATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 347,000 shares 347,000$1.23M0.03%newTimeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 605,531 shares; 2024Q4: 605,531 shares; 2025Q1: 605,531 shares; 2025Q2: 605,531 shares; 2025Q3: 605,531 shares; 2025Q4: 605,531 shares; 2026Q1: 605,531 shares 605,531$1.11M0.02%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MDXHMDXHEALTH SA SHS NEWcall124,306,000$286Mnew
RCELAVITA MEDICAL INC COMcall40,966,100$154Mnew
QGENQIAGEN NV Stockcall250,000$10Mnew
PVLAPALVELLA THERAPEUTICS INC NE COMMON STOCKcall50,000$6.23Mnew
SLNOSOLENO THERAPEUTICS INC COMcall100,000$3.35Mnew

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
MYGNMYRIAD GENETICS INC COMprincipal125,000,000$123Mnew
RCELAVITA MEDICAL INC COMprincipal40,500,000$40.5Mnew
COGENT BIOSCIENCES INCCOGENT BIOSCIENCES INC NOTE 1.625%11/1principal1,000,000$1.22M0

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TERNTERNS PHARMACEUTICALS INC2,153,300$87Mshares
APLSAPELLIS PHARMACEUTICALS INC2,429,868$61Mshares
CITHE CIGNA GROUP205,000$56.4Mshares
RAPTRAPT THERAPEUTICS INC1,642,891$55.6Mshares
UTHRUNITED THERAPEUTICS CORP DEL105,200$51.3Mshares
ROIVROIVANT SCIENCES LTD2,190,907$47.5Mshares
RNAMAVIDITY BIOSCIENCES INC619,530$44.7Mshares
NBIXNEUROCRINE BIOSCIENCES INC314,240$44.6Mshares
EXASEXACT SCIENCES CORP351,716$35.7Mshares
BRKRBRUKER CORP555,789$26.2Mshares
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INC1,226,700$16.4Mshares
CTMXCYTOMX THERAPEUTICS INC.3,525,650$15Mshares
VIRVIR BIOTECHNOLOGY INC2,380,715$14.4Mshares
EWEDWARDS LIFESCIENCES CORP150,000$12.8Mcall
TARSTARSUS PHARMACEUTICALS INC154,400$12.6Mshares
FOLDAMICUS THERAPEUTIC729,900$10.4Mshares
REPARE THERAPEUTICS INCREPARE THERAPEUTICS INC3,322,488$8.64Mshares
CELCCELCUITY INC85,664$8.54Mshares
PMVPPMV PHARMACEUTICALS INC4,975,291$6.22Mshares
INSMINSMED INC25,400$4.42Mshares
OCULOCULAR THERAPEUTIX INC157,300$1.91Mshares
MPLTMAPLIGHT THERAPEUTICS INC56,000$952Kshares
VTGNVISTAGEN THERAPEUTICS INC45,200$29.9Kcall

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-002369 base2026-05-15acceptance time not in the bulk data set